MEDP | Medpace Holdings, Inc. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	339.42 - 350.00
52 Week Range	286.76 - 459.77
Beta	1.32
Implied Volatility	55.02%
IV Rank	55.11%
Day's Volume	204,572
Average Volume	319,088
Shares Outstanding	31,081,600
Market Cap	10,801,477,632
Sector	Healthcare
Industry	Medical - Diagnostics & Research
IPO Date	2016-08-11

Valuation
Profitability
Growth
Health
P/E Ratio	30.38
Forward P/E Ratio	31.60
EPS	11.44
1YR Price Target	267.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	5,900
Country	USA
Website	MEDP

Medpace Holdings Inc is a clinical contract research organization. It is engaged in scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical, and medical device industries. It operates in North America, Europe, Africa, Middle East, Asia-Pacific and Latin America.

MEDP's peers: ACRS, CRL, ICLR, IQV, NEOG, QGEN, WAT, IDXX, RVTY, SYNH, LH, MTD, TWST, MYGN, SHC

*Chart delayed

Analyzing fundamentals for MEDP we got that it has strong fundamentals where Valuation is considered to be fairly valued, Profitability is stunning wealthy, Growth is exceptionally good and Health is weak. For more detailed analysis please see MEDP Fundamentals page.

Watching at MEDP technicals we can see that long-term trend is bearish, while middle-term trend is bullish, as well as bullish short-term trend. More technicals details can be found on MEDP Technicals page.